![](https://www.diabetesnews.com/wp-content/uploads/2012/10/aspirin1-150x150.jpg)
The longer a person took low-dose aspirin, the lower his or her risk for developing pancreatic cancer, according to a study recently published. Men and women who took low-dose aspirin regularly had 48 percent reduction in their risk for developing pancreatic cancer.